Title of Collaborative Activity: |
Best Pharmaceuticals for Children Act (BPCA) Working Group |
Description of Collaborative Activity: |
This group provides safety oversight for all studies conducted under BPCA. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
Year the Collaborative Activity Originated: |
|
NIH Participating Institutes/Centers/Office of the Director: |
NICHD, NHLBI, NCI |
HHS Agency Collaborators on this Activity: |
FDA |
